A skincare startup got bought for $190 million—then shut down. Here's what entrepreneurs can learn from the rise and fall of ...

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company ...

On Monday, Citi analyst Daniel Grosslight confirmed a Sell rating and a $27.00 price target for Hims & Hers Health, Inc.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

An ad for compounded versions of weight-loss drug semaglutide by telehealth company Hims & Hers has attracted the ire of a pharmaceutical trade organisation that calls the campaign "nothing short ...

After hours: March 21 at 8:00:00 PM EDT Loading Chart for HIMS ...

Altimmune to test obesity drug for alcohol use disorder and related health conditions Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...